Our data revealed increased numbers of circulating CD4+IFNγ+ and CD4+IL-17A+T-lymphocytes in new-onset DMARD-naïve RA patients, but normal CD4+IL-4+T-lymphocytes. This evidence concerns the gene IL4 and rheumatoid arthritis.